Document reference

2024/2653(DEA)  
Examination of variations to the terms of marketing authorisations for medicinal products for human use  
Basic information  

2024/2653(DEA)

DEA - Delegated acts procedure


Subject
4.20.01 Medicine, diseases
4.20.04 Pharmaceutical products and industry

Status

Procedure completed - delegated act enters into force

 

Please go to Documentation gateway for any follow-up documents.: Please go to Documentation gateway for any follow-up documents. 
Key players  
Key events  
11/03/2024
Non-legislative basic document published
C(2024)01627
11/03/2024
Initial period for examining delegated act 3 month(s)
13/03/2024
Committee referral announced in Parliament
19/06/2024
Delegated act not objected by Parliament
Technical information  
Procedure reference
2024/2653(DEA)
Procedure type
DEA - Delegated acts procedure
Procedure subtype
Examination of delegated act
Stage reached in procedure
Procedure completed - delegated act enters into force
Committee dossier
ENVI/9/15028
Documentation gateway  
  • European Commission 
    Non-legislative basic document
     
    C(2024)01627  
    11/03/2024
    EC
     
    Document attached to the procedure
     
    SWD(2024)0058 Eur-Lex link  
    11/03/2024
    EC
     
  • All 
    Non-legislative basic document
       
    C(2024)01627  
    11/03/2024
    EC
     
    Document attached to the procedure
       
    SWD(2024)0058 Eur-Lex link  
    11/03/2024
    EC